GlobeNewsWire
03 Sept 2026, 10:50 UTC · 1w ago
Verdict
Headline takes no side. We score PHVS +0.80 across four claims — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Phase 3 RAPIDe-3 trial subgroup analysis showed deucrictibant IR capsules provided consistent symptom relief, severity reduction, and attack resolution across North American and European/RoW populations.
More positive than 91% of claims this week
Deucrictibant IR capsules were generally well tolerated with no serious treatment-related adverse events reported in the RAPIDe-3 subgroup analysis.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 76% of claims this week
Non-human primate (NHP) challenge models successfully predicted the human PK/PD relationship and efficacious doses for deucrictibant.
So whatValidating the dosing model increases confidence in the drug's pharmacological predictability but is less market-moving than Phase 3 clinical results.
More positive than 54% of claims this week
Proteomic analyses identified over 2,600 proteins with differential abundance in patients with bradykinin-mediated angioedema.
More positive than 45% of claims this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company presented positive clinical and nonclinical data for its drug candidate deucrictibant, including successful Phase 3 regional subgroup analysis.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
15h ago
—
No price for PHVS right now — the quote feed didn't answer.
PHVS chart →
